FynnCorp Capital Group, a leading financial advisory firm, has joined forces with DR. CBD, a healthcare and nutraceutical company specializing in hemp and cannabis extracts, to drive growth in Thailand’s emerging hemp and cannabis industry. This strategic partnership aims to position Thailand as a regional hub for the industry and unlock significant economic opportunities.

Pornbhuda Rijiravanich, Managing Director of FynnCorp, announced the partnership, highlighting the company’s commitment to providing comprehensive financial advisory services for businesses operating in the hemp and cannabis sector. “Beyond our core expertise in capital market strategy and innovative financial instruments, we are excited to venture into this rapidly growing industry,” said Pornpud.

FynnCorp and DR. CBD have signed a Memorandum of Understanding (MOU) to collaborate on various initiatives, including:

• Market analysis and opportunity identification: Leveraging data from countries like the United States and Canada, where the hemp and cannabis industries have experienced significant growth, to identify potential opportunities in Thailand.
• Regulatory compliance: Providing guidance on navigating the complex regulatory landscape surrounding hemp and cannabis cultivation, processing, and distribution.
• Capital raising: Facilitating access to capital for companies operating in the hemp and cannabis sector through equity and debt financing.
• Market entry strategy: Assisting companies in developing effective go-to-market strategies to capture a share of the growing Thai market.